Randomized Controlled Phase 2 Study to Evaluate Iptacopan in Participants with Active ANCA-Associated Vasculitis (AAV): Interim Renal-Focused Results (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-OR077; Pres time: Oct 24, 2026; 05:18 PM - 05:30 PM; Location: Four Seasons Ballroom 2; No abstract available
Clinical • Late-breaking abstract • P2 data • ANCA Vasculitis • Vasculitis
|
|
Grégory Pugnet; Benjamin Terrier; Christian Löffler; Zhanzheng Zhao; Sebastian J. Magri; Jorge A. Brigante; Fatma Alibaz-Oner; Rachel B. Jones; Min Chen; Rodolfo N. Alvarado; Adrian Schreiber; Anna Bazsó; Albrecht Betrains; Shilpa Muthusamy; Malika Hanser; Julia Wagner; Swati Ghanshani; Prasanna Kumar Nidamarthy; Imelda Schuhmann; Guido Junge
|